Does time of CCI measurement affect the evaluation of platelet transfusion effectiveness?

Reina Matsui1, Takeshi Hagino2, Nelson Hirokazu Tsuno3

  • 1Department of Laboratory Medicine, Tama-Hokubu Medical Center, Tokyo Metropolitan Health and Medical Treatment Corporation, Tokyo, Japan.

Insights

Corrected count increment (CCI) measured 10-min or 30-min after platelet concentrate (PC) transfusion is comparable to the 1-hour measurement. This finding supports using earlier time points for assessing PC transfusion effectiveness in Japan.

Area of Science:

  • Hematology
  • Transfusion Medicine

Background:

  • The corrected count increment (CCI) at 1-hour post-transfusion is a standard measure for platelet concentrate (PC) effectiveness.
  • Japanese guidelines (2017) revised the recommended measurement window for CCI to 10-min to 1-hour post-transfusion.

Purpose of the Study:

  • To evaluate the feasibility of using CCI measurements at 10-min or 30-min post-transfusion as surrogates for the 1-hour CCI.
  • To assess the comparability of early CCI measurements with the standard 1-hour measurement in the context of Japanese transfusion practices.

Main Methods:

  • Peripheral blood samples were collected at 10-min, 30-min, and 1-hour post-PC transfusion from 8 patients receiving multiple transfusions (total 208).
  • Univariate analyses were performed to identify factors related to CCI values.
  • A mixed-effects model was used to analyze the effect of measurement time on CCI, controlling for significant covariates like gender and fever.

Main Results:

  • Measurement time was found to have a significant effect on CCI values (p = 0.0007).
  • Despite a slight tendency for CCI to decrease over time, the difference between measurements at 10-min, 30-min, and 1-hour was minimal (slope = -0.00307).
  • Gender and fever post-transfusion were also identified as factors influencing CCI.

Conclusions:

  • CCI measurements at 10-min and 30-min post-transfusion provide comparable results to the 1-hour measurement.
  • These early time points can be reliably used to assess PC transfusion effectiveness under Japanese transfusion practices, which utilize single-donor apheresis PC and prioritize ABO compatibility.

Related Concept Videos